Definium's LSD-based pill meets Phase 3 endpoints for depression

June 22, 2026 7:00 AM

Definium Therapeutics (Nasdaq: DFTX) announced positive topline results from its Phase 3 Emerge ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found